Counterfeit Drug Rate Estimates Reach 10% Worldwide
Chris Israel, coordinator for international intellectual property enforcement at the US Department of Commerce, reportedly told Intellectual Property Watch that one could not help seeing the issue of counterfeit medicines as having more of a human impact than other counterfeit issues:
For more information on counterfeit drugs, visit www.safemedicines.org.
However, he noted that this issue was “part of a larger environment” and the issue was linked with other counterfeit issues. Thus they all had to be fought with “equal energy,” he said. Critics have charged that industry and government have at times held up incidents in the pharmaceutical and airplane parts industries to win public
sympathy for an overall anti-counterfeit agenda.
The issue of whether lower prices in general would reduce the amount of counterfeits was not discussed at the conference but when asked about the issue, Israel replied that “those are market decisions.” He said that his unit’s focus was to create an environment to confront stolen intellectual property, while the companies’ role was to produce the best products possible. “Our primary focus should be on enforcement,” Israel said.